Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Tasly and Genexine-backed drug developer floated above the mid-point of its range, in an initial public offering that could end up topping $119m.

SymphonyAI Group has taken part in a $150m round for one of its spinoffs, precision cancer therapy developer Concerto HealthAI.

Naver has backed four health and education technology developers – Huray Positive, Ichrogene, N.Cer and SoundGym – through its D2 Startup Factory accelerator.

Foxconn, SK Telecom and Fujifilm have all returned for a round that increased X-ray diagnosis platform developer Nano-X Imaging's overall funding to $55m.

Evive has acquired the medical-treatment comparison platform, which had raised $16.3m in equity and debt financing from investors including Merck GHI.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Wilson Sonsini Goodrich & Rosati has invested in genomic sequencing amplification business Bioskryb, co-founded by Stanford faculty member Charles Gawad.

Takeda Ventures converted debt financing into equity through the genetic medicine developer's latest round, which was led by strategic partner AnGes.